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Establishment of an Immortalized Human Subglottic Epithelial
Cell Line
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Objective: Translational research into subglottic disease is restricted by the availability of primary human tissue originat-
ing from this subsite. Primary epithelial cells are also limited by their inability to survive beyond several divisions in culture
outside of the body. Specific subglottic cell lines, useful for in vitro studies, have not yet been described. We therefore demon-
strate what we believe to be the first immortalized subglottic epithelial cell line.
Methods: Subglottic tissue was derived from a single adult patient’s neoplasia-free human subglottic brushing specimen.
Cells were immortalized using a lentiviral vector expressing simian virus 40 T antigen. Karyotyping was performed on the
transformed cells using single nucleotide polymorphism array comparative genomic hybridization. Transformed cells were
phenotypically characterized by light microscopy, immunohistochemistry, and electrophysiology studies.
Results: The immortalized subglottic cell line (SG01) was able to divide successfully beyond 20 passages. Karyotyping
demonstrated no significant genomic imbalance after immortalization. The cells demonstrated normal epithelial morphology
and cytokeratin expression throughout. SG01 cells were also successfully cultured at air–liquid interface (ALI). At ALI cells
demonstrated cilia, mucus production, and relevant ion channel expression.
Conclusion: The novel SG01 subglottic epithelial cell line has been established. This cell line provides a unique resource
for researchers to investigate subglottic diseases, such as subglottic stenosis.
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INTRODUCTION
The subglottis is a crucial site for airway infection,
inflammation, and malignancy.1–3 Subglottic stenosis is
one of the most common pathologies in this region.
Found in both children and adults, it can result in
potentially life-threatening airway obstruction.4
Approximately 90% of all cases of acquired subglottic
stenosis result from endotracheal intubation, with a
reported rate of stenosis following intubation ranging
from 0.9% to 8.3%.5 The subglottis is also a potential
site of laryngeal cancer.6 Although rare, subglottic
malignancy is nonetheless associated with late presen-
tation and a poor prognosis.6 The subglottis also has a
crucial relationship with the lower airway in terms of
infection.7 This importance is epitomized in intubated
and mechanically ventilated patients at high risk of
ventilator-associated pneumonia for whom removal of
infected secretions from the subglottis can reduce the
incidence of pneumonia.8,9
Translational research relies on human samples to
perform in vitro experimentation, such as eliciting dis-
ease pathophysiology or bench-testing new potential ther-
apeutic agents.10–12 This research is hampered by the
availability of primary human tissue originating from
this difficult to sample site.10–12 Previous researchers
have used animal models or human tissue from other air-
way locations, such as the nose or lung; however, this is
unlikely to fully recapitulate the subglottic airway in
humans, which is a distinct respiratory niche.13,14 We
have previously reported the first description of primary
human subglottic epithelial cell culture.7 Although estab-
lishing techniques for the sampling and culture of these
primary cells is important, not all researchers will have
access to these human samples. In addition, primary epi-
thelial cells obtained from patients are limited by their
inability to survive beyond several divisions in culture
outside of the body.15 Specific subglottic cell lines, useful
for in vitro studies, have not yet been described. We
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therefore demonstrate what we believe to be the first
immortalized human subglottic epithelial cell line.
MATERIALS AND METHODS
Collection of Subglottic Samples
The appropriate ethical committees and hospital institu-
tions granted approval for the study. Participants were recruited
from otolaryngology–head and neck surgery waiting lists
(Freeman Hospital, Newcastle upon Tyne, UK) prior to planned
general anesthetic microlaryngoscopy. Exclusion criteria
included patients with current or previous head and neck malig-
nancy or with structural subglottic pathology. Subglottic mucosal
brushings were obtained under direct microscopic vision in the
operating room via a sheathed cytology brush (BC-202D-5010,
Olympus, Japan), as previously described.7 The cytology brush
was placed in a sterile container containing tissue culture medium
(Roswell Park Memorial Institute-1640, Sigma, Gillingham, UK)
for immediate transport to the laboratory on ice.
Tissue Culture
Epithelial cell culture and passage were performed using
methods previously described.7,16 In brief, samples were separated
from the brush head, pelleted, and then cultured on collagen-coated
flasks in bronchial epithelial growth medium (BEGM) (CC-4175,
Lonza, Basel, Switzerland), supplemented with penicillin/strepto-
mycin 100 U/mL (Sigma, Gillingham, UK), incubated at 37C in a
5% CO2 incubator. Medium was changed every 2 to 3 days. Passage
was performed when cells reached 70% to 80% confluence. The cells
were removed from the culture surface with trypsin 0.05% (Sigma,
Gillingham, UK), neutralized with 10% Fetal Bovine Serum
(Sigma, Gillingham, UK), centrifuged, and then placed in a new
growth container. Cells were also cultured at air–liquid interface
(ALI), for which cells are exposed to air apically and medium
basally. In these conditions, respiratory epithelial cells typically
differentiate into a pseudostratified respiratory epithelium with
ciliated and mucus-producing cells.17 To achieve this, cells were
passaged onto transwell inserts (0.4-μm pore size, Corning, Corn-
ing, NY) and cultured with BEGM medium supplemented with
SingleQuots (Lonza, Switzerland) and antibiotics.16,18
Cell Immortalization
Primary subglottic epithelial cells at passage 1 were trans-
fected with a simian virus 40 (SV40) cell immortalization system,
utilizing a recombinant lentiviral vector (106 IU/mL) (Applied
Biological Materials, Inc., Vancouver, Canada), supplemented
with 10 μg/mL Polybrene (Sigma). After transfection, cells were
cultured as previously described. As per the manufacturer’s
instructions, the clonal population was selected by the ability of
only the immortalized cells to survive senescence, which nor-
mally occurred in primary subglottic epithelial cells between
three to five passages. Immortalization was confirmed by contin-
uous culture past 20 passages. Epithelial morphology was con-
firmed on light microscopy. Comparison of immortalized cells
was made with nonimmortalized primary subglottic epithelial
cells, which have been extensively characterized by Powell et al.7
Karyotyping
Single nucleotide polymorphism (SNP) array comparative
genomic hybridization (CGH) was performed by the Northern
Genetics Service, Newcastle upon Tyne, UK. DNA was extracted
from two confluent culture flasks containing immortalized cells
(passage 16) using the EZ1 DNA Tissue Kit (Qiagen, Hilden,
Germany) on the EZ1 Advanced XL Robot (Qiagen, Germany).
The DNA was quantified using standard procedures. SNP array
CGH was carried out using whole genome Infinium CytoSNP-
850 K v1.1 BeadChip Array (Illumina, San Diego, CA). Analysis
was performed on BlueFuse Multi v4.4 using Genome Build
GRCh37 (Illumna, San Diego, CA). The backbone average resolu-
tion was approximately 50 kb.
Immunohistochemistry
Cytokeratin staining was performed to confirm the epithe-
lial phenotype. Cultures were fixed and permeabilized with
methanol, then stained with monoclonal anti-cytokeratin (pan-
reactive) antibody (raised in mouse), conjugated with Alexa
Fluor 647 (Biolegend, San Diego, CA), counterstained with
40,6-diamidino-2-phenylindole dihydrochloride (DAPI) nuclear
stain. Imaging was performed with a confocal fluorescent camera
(Axio Imager II, Zeiss, Oberkochen, Germany).
Electrophysiological Studies
Ussing chamber studies were used to characterize the electro-
physiological properties of epithelial cells, such as relevant ion chan-
nel expression and transepithelial resistance. Experiments were
performed using a static chamber system (World Precision Instru-
ments, Sarasota FL).19 Apical and basolateral compartments were
electrically isolated and separated by the polarized epithelial layer.
A symmetrical Krebs solution was added to both compartments to
eliminate potentially influential osmotic and chemical effects. Calo-
mel voltage-sensing electrodes were placed on each side of the mem-
brane. Transepithelial potential difference was clamped to 0 mV by
current injection with silver–silver chloride electrodes to eliminate
the voltage gradient. 3 M potassium chloride salt bridges containing
3% agar were used to connect chambers to the electrodes. The cham-
ber was maintained at 37C and continuously gassed with 5%
CO2/95% O2, pH 7.4. A 1 second 5 mV pulse was applied at
30-second intervals to monitor resistance changes, calculated by
applying Ohm’s law. After 20 minutes of stabilization, relevant ion
channel inhibitors and activators were added, and the resultant
short-circuit current (Isc) responses were recorded. Apical amiloride
(Sigma) was added to inhibit epithelial sodium channels (ENaC).
Apical forskolin (Sigma) was added to activate cystic fibrosis trans-
membrane conductance regulator (CFTR)-mediated chloride trans-
port through adenylate cyclase stimulation and intracellular cAMP
increase. CFTR was inhibited by apical addition of CFTRinh172
(Sigma). The resultant analogue signal was digitized with a Power-
Lab 200 interface (AD instruments, Oxford, UK) and recorded by a
computer with Scope 3.8.8 software (AD Instruments).
RESULTS
Primary subglottic epithelial cell cultures were estab-
lished from a neoplasia-free human subglottic brushing
specimen. The sample was obtained from a 65-year-old
Caucasian male. The donor was a nonsmoker. The indica-
tion for microlaryngoscopy was persistent throat symp-
toms. No abnormality was identified on examination in the
operating room. These subglottic primary cells were suc-
cessfully immortalized to form SG01 cells. A second sam-
ple (from a separate patient) was also successfully
immortalized to confirm the technique was reproducible.
The immortalized subglottic epithelial cells (SG01
cells) display normal epithelial cell morphology on light
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Fig. 1. Brightfield light micrograph of immortalized (SG01) and nonimmortalized (control) subglottic epithelial cells cultured under submerged
conditions (×20 magnification). Submerged cultures of SG01 cells demonstrate typical cobblestone appearance of respiratory epithelial cells.
P = passage; SG01 = subglottic cell line.
Fig. 2. Pan-cytokeratin staining of immortalized subglottic epithelial cells. Immortalized SG01 cells at passage 15 were fixed and stained with
anti-cytokeratin (pan-reactive) antibody, then mounted in medium containing DAPI. A confocal fluorescent camera (Zeiss Axio Imager II, Ger-
many) was used to image the cells. (A) DAPI nuclei stain (blue); (B) anti-cytokeratin (pan-reactive) antibody, conjugated with Alexa Fluor
647 (Biolegend, San Diego, CA) (red); (C) combined image of DAPI and cytokeratin; (D) background control to which the other images
were set. DAPI = 40,6-diamidino-2-phenylindole dihydrochloride; SG01 = subglottic cell line. [Color figure can be viewed in the online issue,
which is available at www.laryngoscope.com.]
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microscopy (Fig. 1) and expression of cytokeratin, an epi-
thelial cell marker (Fig. 2). SNP array CGH karyotyping
demonstrated a male genotype with no significant geno-
mic imbalance, no evidence of mosaicism, no loss of het-
erozygosity, and no uniparental disomy (Fig. 3). Cells
have been expanded and cultured successfully beyond
20 passages.
SG01 were also successfully lifted onto an ALI cul-
ture system. The cells had the apical fluid removed and
differentiated by day 25. Brightfield light microscopy dem-
onstrated, on repeated occasions, characteristic epithelial
morphology and growth, including mucus production and
cilia. Tight epithelial junctions were confirmed by resis-
tance measurements on Ussing chamber experiments
Fig. 3. B-allele chart demonstrating a male genotype with no significant genomic imbalance. Single nucleotide polymorphism array compara-
tive genomic hybridization karyotyping was performed on DNA extracted from immortalized subglottic cell line cells at passage 16. B-allele
chart demonstrates chromosomal position (x-axis) and b-allele frequency (y-axis), showing no significant genomic imbalance. [Color figure can
be viewed in the online issue, which is available at www.laryngoscope.com.]
Fig. 4. Ussing chamber experiments were performed on immortalized subglottic epithelial cells at passage 12 (day 30 and 50) at air–liquid interface
culture. The Isc values reflect anion (Cl−) secretion and/or cation absorption (Na+). Transepithelial potential difference was measured (RTE). Immor-
talized cells demonstrated relevant ion channels expected of respiratory epithelial cells. AMIL was added to inhibit ENaC. Apical FSK was added
to activate CFTR-mediated chloride transport. CFTR was inhibited by apical addition of CFTRinh172. ATP was used to activate calcium-activated
chloride channels. AMIL = apical amiloride; ATP = adenosine triphosphate; CFTR = cystic fibrosis transmembrane conductance regulator;
ENaC = epithelial sodium channels; FSK = forskolin; lsc = short-circuit current; RTE = transepithelial tissue resistance; SG01 = subglottic cell line.
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(Fig. 4). Relevant ion channel expression was also con-
firmed on Ussing chamber experiments, including ENaC
and CFTR (Fig. 4).
DISCUSSION
We describe, to our knowledge, the first immortalised
human subglottic epithelial cell line, SG01. This model
provides a unique resource for researchers to study sub-
glottic diseases and potentially test therapeutic agents
with a site-specific in vitro model. We have confirmed that
the SG01 cell line is highly representative of both primary
in vitro cultures and the subglottic environment in vivo.
Valid experimental models are required to further eluci-
date the pathogenesis of subglottic diseases, such as subglot-
tic stenosis and malignancy, and to develop therapeutic
agents prior to human trials. The importance of cell culture
models—in particular the immortalized epithelial cell
models—in drug discovery and epithelial biology (including
cancer biology) over the past half-century cannot be
overstated.10–12 The significant limitations of animal models
in translational research have been extensively discussed
elsewhere.20–23 Translational researchers are increasingly
reliant on appropriate in vitromodels as an alternative to ani-
mal testing.10,11 Primary cells, although superior to immor-
talized cell lines in terms of in vitro use, have significant
limitations. The culture of primary cells is more invasive for
patients, labor-intensive for investigators, and expensive.10,11
Primary cells are also limited by their finite lifespan outside
of the body.15 Immortalized cell lines originate from one
patient sample and are therefore more homogeneous. This
removes interpatient sample variability between tests, mak-
ing immortalized cells much more useful for the screening of
large numbers of new drug candidates at low cost with high
reliability and within a short time span.10–12
Human primary epithelial cell cultures and cell lines
have previously been established from other airway loca-
tions, including the posterior commissure, trachea, and
small airways of the lung.16,24–26 These are, however,
unlikely to reflect the subglottic region. The subglottis is an
anatomically distinct region of the airway, differentiated
from the trachea due to its circumferential binding to the
cricoid cartilage, giving it unique physical properties.13,14
These distinctive properties include a large number of sero-
mucous glands present in the submucosa and a dense sube-
pithelial capillary plexus with numerous anastomoses.14
Several methods exist for immortalizing mammalian
cells in culture. Cells were immortalized using a lenti-
viral vector expressing SV40 T antigen. This mechanism
of immortalization is well documented as having a stable
genetic background. SV40 T antigen has been shown to
be one of the most reliable agents for the immortalization
of cells in culture, and the mechanism has been well
documented.27–31 Multiple other human epithelial sub-
sites have been immortalized utilizing SV40, including
esophageal, corneal, ovarian, and urinary tract.29,32–34
The technique has also been applied to nonepithelial
cells, such as neural, epidermal, and endothelial cells, in
humans and other mammals.35–37
A potential limitation of this model is that it utilized
subglottic cells sampled from a patient undergoing
microlaryngoscopy for the diagnosis of persistent upper
airway symptoms. The examination was normal, and no
subglottic pathology was encountered. However, these
symptoms could be due to laryngopharyngeal reflux, which
has been shown to alter laryngeal cell phenotype.38–40 The
samples had to be obtained during general anesthesia due
to the difficulty in accessing the subglottis; therefore, it
was not possible to access subglottic samples from
completely asymptomatic patients (who would not be
undergoing this procedure). Another limitation of this
study is the age of the patients sampled. Although subglot-
tic malignancy is almost entirely found in adults, subglot-
tic stenosis is more commonly found in children. To our
knowledge, there is no specific literature comparing the
pediatric and adult subglottis at an epithelial level. There
is, however, the potential for difference. Establishment of
a pediatric version of this cell line would be an area for fur-
ther research.
CONCLUSION
The novel SG01 subglottic epithelial cell line has
been established. This cell line provides a unique
resource for researchers to investigate subglottic diseases,
such as subglottic stenosis. SG01 cells divide successfully
beyond 20 passages; can differentiate at ALI culture; and
demonstrate normal epithelial morphology, cytokeratin
expression, and relevant ion channel expression.
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